Symprove are Research Led
In the 1990s it became very apparent there was a need for a totally different bacteria formula which could withstand the volatile pH conditions of the gastrointestinal tract. Symprove Ltd was established in 2002 following the launch of an R&D programme to produce a formula for human consumption. The R&D function continues to be the lifeblood of the company.
Following extensive research, a range of independent testing, as well as meeting the challenges of all the regulatory bodies for transfer of technology to humans, the company started selling Symprove in Autumn 2008.
Symprove Ltd has now grown and its Board of Directors include some eminent physicians, industry experts and business leaders, providing a wealth of experience and knowledge.
The company continues to be research driven and is constantly striving to prove efficacy across different indications.
Looking after super-sensitive bacteria is a challenge for any organisation or scientist. At Symprove, we know how important it is to help our 4 species of naturally occurring 'friendly' bacteria, every step of the way because they are live and activated.
As living organisms, these sensitive microorganisms do not like being subject to extremes, so everything we do throughout the production process has their best interests at heart. And like anything 'living', our bacteria enjoy good food too.
The Symprove Unique Delivery System (UDS™) is a proprietary technology and patents are pending worldwide.
Buy Symprove today at Simply Sunshine.